
Media
Media
Our latest announcements
Hansa Biopharma has carried out a directed cash share issue of approx. mSEK 232 and entered into binding agreement to restructure debt held by NovaQuest, including set-off issue of USD 14.9 million
Regulatory press release
19/06/2025
Hansa Biopharma intends to carry out directed share issue of approximately 10 million shares and has entered into non-binding terms with NovaQuest to restructure debt
Regulatory press release
18/06/2025
Hansa Biopharma to attend BIO International Convention
11/06/2025
Hansa Biopharma to Host Science Deep Dive Virtual Investor Event on Guillain-Barré Syndrome on June 16, 2025
09/06/2025
Media articles
Insights
Collaboration across the continuum of care to improve equity for highly sensitized people in kidney transplantation
17/07/2024
A concerted collaboration to advance treatment options for people living with rare diseases
26/06/2024
Fueling the future: the role of biotech in advancing innovative science and delivering new medicines
02/05/2024
Addressing barriers to gene therapy treatment
31/01/2024
Global Corporate Affairs
Stephanie Kenney
Vice President Global Corporate Affairs
Email: [email protected]